Morning Read: A Pfizer-Allergan acquisition is in the works, Allergan’s Warner Chilcott coughs up $125M to settle kickback charges
Pfizer and Allergan are in acquisition talks.
Pfizer and Allergan are in acquisition talks.
As Warner Chilcott (NASDAQ: WCRX) acknowledged in an announcement Monday that it is considering strategic options, it’s good time to look at what the company has to offer a prospective buyer in what has become a busy M&A landscape. The Irish company’s products were mostly acquired from Bristol-Myers Squibb, Lilly, Pfizer and Procter & Gamble. […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.